Precigen, Inc. Common Stock (NASDAQ: PGEN) last traded at $7.65, up 2.27% on the session. The quote above updates while this page is open; the figures below are drawn from Precigen, Inc. Common Stock’s own filings and are restated only when a new one is published.
Precigen, Inc. Common Stock trades on NASDAQ under the ticker PGEN. Its market capitalisation is $2.74 billion.
Valuation measures for Precigen, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.74B |
|---|---|
| Enterprise value | $2.85B |
| Price / sales | 282.83 |
| Price / book | 62.86 |
| Beta | 1.37 |
Trailing-twelve-month figures tagged in Precigen, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $9.68M |
|---|---|
| Net income (TTM) | -$157.71M |
| Operating margin | -1141.13% |
| Return on equity | -361.91% |
| Cash | $16.33M |
Range and volume for PGEN over the past 52 weeks.
| 52-week high | $8.98 |
|---|---|
| 52-week low | $3.04 |
| Volume | 1.82M |
| Average volume | 4.93M |
| Previous close | $7.48 |
Invest a chosen dollar amount in Precigen, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell PGEN.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.